Global Soft-Contact Blood Lancet Market Growth 2026-2032
The global Soft-Contact Blood Lancet market size is predicted to grow from US$ 941 million in 2025 to US$ 1298 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.
In 2025, the global annual production capacity of soft-contact blood lancets was approximately 19.5 billion units, while actual output reached around 16.03 billion units. The global average selling price was approximately US$0.060 per unit. Supported by large-scale automated manufacturing and stable demand from chronic disease management, major manufacturers maintained gross profit margins in the range of 30%–45%. Soft-contact blood lancets are disposable medical devices used for capillary blood sampling. They incorporate a soft-contact or pressure-activated mechanism that minimizes skin trauma and reduces pain during puncture while ensuring consistent penetration depth. These lancets are widely applied in blood glucose monitoring, point-of-care testing, and home healthcare scenarios.
Upstream of the soft-contact blood lancet supply chain consists of medical-grade stainless steel needles, polymer resins, spring components, packaging materials, and sterilization consumables. Midstream manufacturers focus on precision injection molding, needle grinding, automated assembly, sterilization, and quality control, with major production centers located in China, the United States, Europe, and Southeast Asia. Downstream channels include hospitals, diagnostic laboratories, pharmacies, medical distributors, and home healthcare brands. End users place strong emphasis on safety, pain reduction, sterility assurance, consistency, and compatibility with various lancing devices.
The soft-contact blood lancet market in 2025 is supported by the continued rise in diabetes prevalence and the expansion of home-based healthcare. Compared with traditional lancets, soft-contact designs provide better user comfort and improved sampling consistency, driving their gradual replacement of conventional products. Although unit prices remain relatively low, high shipment volumes and automated manufacturing enable suppliers to maintain stable margins. Regulatory compliance and sterilization standards remain key barriers to entry. Future growth will be driven by chronic disease management, aging populations, and increasing healthcare accessibility in emerging markets.
LP Information, Inc. (LPI) ' newest research report, the “Soft-Contact Blood Lancet Industry Forecast” looks at past sales and reviews total world Soft-Contact Blood Lancet sales in 2025, providing a comprehensive analysis by region and market sector of projected Soft-Contact Blood Lancet sales for 2026 through 2032. With Soft-Contact Blood Lancet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soft-Contact Blood Lancet industry.
This Insight Report provides a comprehensive analysis of the global Soft-Contact Blood Lancet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Soft-Contact Blood Lancet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Soft-Contact Blood Lancet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soft-Contact Blood Lancet and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soft-Contact Blood Lancet.
This report presents a comprehensive overview, market shares, and growth opportunities of Soft-Contact Blood Lancet market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
In 2025, the global annual production capacity of soft-contact blood lancets was approximately 19.5 billion units, while actual output reached around 16.03 billion units. The global average selling price was approximately US$0.060 per unit. Supported by large-scale automated manufacturing and stable demand from chronic disease management, major manufacturers maintained gross profit margins in the range of 30%–45%. Soft-contact blood lancets are disposable medical devices used for capillary blood sampling. They incorporate a soft-contact or pressure-activated mechanism that minimizes skin trauma and reduces pain during puncture while ensuring consistent penetration depth. These lancets are widely applied in blood glucose monitoring, point-of-care testing, and home healthcare scenarios.
Upstream of the soft-contact blood lancet supply chain consists of medical-grade stainless steel needles, polymer resins, spring components, packaging materials, and sterilization consumables. Midstream manufacturers focus on precision injection molding, needle grinding, automated assembly, sterilization, and quality control, with major production centers located in China, the United States, Europe, and Southeast Asia. Downstream channels include hospitals, diagnostic laboratories, pharmacies, medical distributors, and home healthcare brands. End users place strong emphasis on safety, pain reduction, sterility assurance, consistency, and compatibility with various lancing devices.
The soft-contact blood lancet market in 2025 is supported by the continued rise in diabetes prevalence and the expansion of home-based healthcare. Compared with traditional lancets, soft-contact designs provide better user comfort and improved sampling consistency, driving their gradual replacement of conventional products. Although unit prices remain relatively low, high shipment volumes and automated manufacturing enable suppliers to maintain stable margins. Regulatory compliance and sterilization standards remain key barriers to entry. Future growth will be driven by chronic disease management, aging populations, and increasing healthcare accessibility in emerging markets.
LP Information, Inc. (LPI) ' newest research report, the “Soft-Contact Blood Lancet Industry Forecast” looks at past sales and reviews total world Soft-Contact Blood Lancet sales in 2025, providing a comprehensive analysis by region and market sector of projected Soft-Contact Blood Lancet sales for 2026 through 2032. With Soft-Contact Blood Lancet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soft-Contact Blood Lancet industry.
This Insight Report provides a comprehensive analysis of the global Soft-Contact Blood Lancet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Soft-Contact Blood Lancet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Soft-Contact Blood Lancet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soft-Contact Blood Lancet and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soft-Contact Blood Lancet.
This report presents a comprehensive overview, market shares, and growth opportunities of Soft-Contact Blood Lancet market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Safety
- Routine
- Standard Length
- Short-length
- Long-length
- Newborn Screening
- Blood Glucose Test
- Rapid Complete Blood Count
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Lifescan
- BD
- MTD Group
- Greiner Bio One
- Owen Mumford
- Cardinal Health
- Ascensia
- Abbott
- B. Braun
- Terumo
- I-SENS
- Nipro
- ICU Medical
- Sarstedt
- Sannuo Biosensor
- Yuwell Medical
- Tianjin Huahong
- Suzhou Slink Medical
- Shandong Lianfa
- Puan Medical
- What is the 10-year outlook for the global Soft-Contact Blood Lancet market?
- What factors are driving Soft-Contact Blood Lancet market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Soft-Contact Blood Lancet market opportunities vary by end market size?
- How does Soft-Contact Blood Lancet break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Soft-Contact Blood Lancet Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Soft-Contact Blood Lancet by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Soft-Contact Blood Lancet by Country/Region, 2021, 2025 & 2032
2.2 Soft-Contact Blood Lancet Segment by Type
2.2.1 Safety
2.2.2 Routine
2.2.3 Soft-Contact Blood Lancet Sales by Type
2.2.3.1 Global Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
2.2.3.2 Global Soft-Contact Blood Lancet Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Soft-Contact Blood Lancet Sale Price by Type (2021-2026)
2.3 Soft-Contact Blood Lancet Segment by Length
2.3.1 Standard Length
2.3.2 Short-length
2.3.3 Long-length
2.3.4 Soft-Contact Blood Lancet Sales by Length
2.3.4.1 Global Soft-Contact Blood Lancet Sales Market Share by Length (2021-2026)
2.3.4.2 Global Soft-Contact Blood Lancet Revenue and Market Share by Length (2021-2026)
2.3.4.3 Global Soft-Contact Blood Lancet Sale Price by Length (2021-2026)
2.4 Soft-Contact Blood Lancet Segment by Application
2.4.1 Newborn Screening
2.4.2 Blood Glucose Test
2.4.3 Rapid Complete Blood Count
2.4.4 Others
2.4.5 Soft-Contact Blood Lancet Sales by Application
2.4.5.1 Global Soft-Contact Blood Lancet Sale Market Share by Application (2021-2026)
2.4.5.2 Global Soft-Contact Blood Lancet Revenue and Market Share by Application (2021-2026)
2.4.5.3 Global Soft-Contact Blood Lancet Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Soft-Contact Blood Lancet Breakdown Data by Company
3.1.1 Global Soft-Contact Blood Lancet Annual Sales by Company (2021-2026)
3.1.2 Global Soft-Contact Blood Lancet Sales Market Share by Company (2021-2026)
3.2 Global Soft-Contact Blood Lancet Annual Revenue by Company (2021-2026)
3.2.1 Global Soft-Contact Blood Lancet Revenue by Company (2021-2026)
3.2.2 Global Soft-Contact Blood Lancet Revenue Market Share by Company (2021-2026)
3.3 Global Soft-Contact Blood Lancet Sale Price by Company
3.4 Key Manufacturers Soft-Contact Blood Lancet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Soft-Contact Blood Lancet Product Location Distribution
3.4.2 Players Soft-Contact Blood Lancet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SOFT-CONTACT BLOOD LANCET BY GEOGRAPHIC REGION
4.1 World Historic Soft-Contact Blood Lancet Market Size by Geographic Region (2021-2026)
4.1.1 Global Soft-Contact Blood Lancet Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Soft-Contact Blood Lancet Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Soft-Contact Blood Lancet Market Size by Country/Region (2021-2026)
4.2.1 Global Soft-Contact Blood Lancet Annual Sales by Country/Region (2021-2026)
4.2.2 Global Soft-Contact Blood Lancet Annual Revenue by Country/Region (2021-2026)
4.3 Americas Soft-Contact Blood Lancet Sales Growth
4.4 APAC Soft-Contact Blood Lancet Sales Growth
4.5 Europe Soft-Contact Blood Lancet Sales Growth
4.6 Middle East & Africa Soft-Contact Blood Lancet Sales Growth
5 AMERICAS
5.1 Americas Soft-Contact Blood Lancet Sales by Country
5.1.1 Americas Soft-Contact Blood Lancet Sales by Country (2021-2026)
5.1.2 Americas Soft-Contact Blood Lancet Revenue by Country (2021-2026)
5.2 Americas Soft-Contact Blood Lancet Sales by Type (2021-2026)
5.3 Americas Soft-Contact Blood Lancet Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Soft-Contact Blood Lancet Sales by Region
6.1.1 APAC Soft-Contact Blood Lancet Sales by Region (2021-2026)
6.1.2 APAC Soft-Contact Blood Lancet Revenue by Region (2021-2026)
6.2 APAC Soft-Contact Blood Lancet Sales by Type (2021-2026)
6.3 APAC Soft-Contact Blood Lancet Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Soft-Contact Blood Lancet by Country
7.1.1 Europe Soft-Contact Blood Lancet Sales by Country (2021-2026)
7.1.2 Europe Soft-Contact Blood Lancet Revenue by Country (2021-2026)
7.2 Europe Soft-Contact Blood Lancet Sales by Type (2021-2026)
7.3 Europe Soft-Contact Blood Lancet Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Soft-Contact Blood Lancet by Country
8.1.1 Middle East & Africa Soft-Contact Blood Lancet Sales by Country (2021-2026)
8.1.2 Middle East & Africa Soft-Contact Blood Lancet Revenue by Country (2021-2026)
8.2 Middle East & Africa Soft-Contact Blood Lancet Sales by Type (2021-2026)
8.3 Middle East & Africa Soft-Contact Blood Lancet Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Soft-Contact Blood Lancet
10.3 Manufacturing Process Analysis of Soft-Contact Blood Lancet
10.4 Industry Chain Structure of Soft-Contact Blood Lancet
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Soft-Contact Blood Lancet Distributors
11.3 Soft-Contact Blood Lancet Customer
12 WORLD FORECAST REVIEW FOR SOFT-CONTACT BLOOD LANCET BY GEOGRAPHIC REGION
12.1 Global Soft-Contact Blood Lancet Market Size Forecast by Region
12.1.1 Global Soft-Contact Blood Lancet Forecast by Region (2027-2032)
12.1.2 Global Soft-Contact Blood Lancet Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Soft-Contact Blood Lancet Forecast by Type (2027-2032)
12.7 Global Soft-Contact Blood Lancet Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Soft-Contact Blood Lancet Product Portfolios and Specifications
13.1.3 Roche Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Lifescan
13.2.1 Lifescan Company Information
13.2.2 Lifescan Soft-Contact Blood Lancet Product Portfolios and Specifications
13.2.3 Lifescan Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Lifescan Main Business Overview
13.2.5 Lifescan Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Soft-Contact Blood Lancet Product Portfolios and Specifications
13.3.3 BD Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 MTD Group
13.4.1 MTD Group Company Information
13.4.2 MTD Group Soft-Contact Blood Lancet Product Portfolios and Specifications
13.4.3 MTD Group Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MTD Group Main Business Overview
13.4.5 MTD Group Latest Developments
13.5 Greiner Bio One
13.5.1 Greiner Bio One Company Information
13.5.2 Greiner Bio One Soft-Contact Blood Lancet Product Portfolios and Specifications
13.5.3 Greiner Bio One Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Greiner Bio One Main Business Overview
13.5.5 Greiner Bio One Latest Developments
13.6 Owen Mumford
13.6.1 Owen Mumford Company Information
13.6.2 Owen Mumford Soft-Contact Blood Lancet Product Portfolios and Specifications
13.6.3 Owen Mumford Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Owen Mumford Main Business Overview
13.6.5 Owen Mumford Latest Developments
13.7 Cardinal Health
13.7.1 Cardinal Health Company Information
13.7.2 Cardinal Health Soft-Contact Blood Lancet Product Portfolios and Specifications
13.7.3 Cardinal Health Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cardinal Health Main Business Overview
13.7.5 Cardinal Health Latest Developments
13.8 Ascensia
13.8.1 Ascensia Company Information
13.8.2 Ascensia Soft-Contact Blood Lancet Product Portfolios and Specifications
13.8.3 Ascensia Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Ascensia Main Business Overview
13.8.5 Ascensia Latest Developments
13.9 Abbott
13.9.1 Abbott Company Information
13.9.2 Abbott Soft-Contact Blood Lancet Product Portfolios and Specifications
13.9.3 Abbott Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Abbott Main Business Overview
13.9.5 Abbott Latest Developments
13.10 B. Braun
13.10.1 B. Braun Company Information
13.10.2 B. Braun Soft-Contact Blood Lancet Product Portfolios and Specifications
13.10.3 B. Braun Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 B. Braun Main Business Overview
13.10.5 B. Braun Latest Developments
13.11 Terumo
13.11.1 Terumo Company Information
13.11.2 Terumo Soft-Contact Blood Lancet Product Portfolios and Specifications
13.11.3 Terumo Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Terumo Main Business Overview
13.11.5 Terumo Latest Developments
13.12 I-SENS
13.12.1 I-SENS Company Information
13.12.2 I-SENS Soft-Contact Blood Lancet Product Portfolios and Specifications
13.12.3 I-SENS Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 I-SENS Main Business Overview
13.12.5 I-SENS Latest Developments
13.13 Nipro
13.13.1 Nipro Company Information
13.13.2 Nipro Soft-Contact Blood Lancet Product Portfolios and Specifications
13.13.3 Nipro Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Nipro Main Business Overview
13.13.5 Nipro Latest Developments
13.14 ICU Medical
13.14.1 ICU Medical Company Information
13.14.2 ICU Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
13.14.3 ICU Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 ICU Medical Main Business Overview
13.14.5 ICU Medical Latest Developments
13.15 Sarstedt
13.15.1 Sarstedt Company Information
13.15.2 Sarstedt Soft-Contact Blood Lancet Product Portfolios and Specifications
13.15.3 Sarstedt Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sarstedt Main Business Overview
13.15.5 Sarstedt Latest Developments
13.16 Sannuo Biosensor
13.16.1 Sannuo Biosensor Company Information
13.16.2 Sannuo Biosensor Soft-Contact Blood Lancet Product Portfolios and Specifications
13.16.3 Sannuo Biosensor Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Sannuo Biosensor Main Business Overview
13.16.5 Sannuo Biosensor Latest Developments
13.17 Yuwell Medical
13.17.1 Yuwell Medical Company Information
13.17.2 Yuwell Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
13.17.3 Yuwell Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Yuwell Medical Main Business Overview
13.17.5 Yuwell Medical Latest Developments
13.18 Tianjin Huahong
13.18.1 Tianjin Huahong Company Information
13.18.2 Tianjin Huahong Soft-Contact Blood Lancet Product Portfolios and Specifications
13.18.3 Tianjin Huahong Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Tianjin Huahong Main Business Overview
13.18.5 Tianjin Huahong Latest Developments
13.19 Suzhou Slink Medical
13.19.1 Suzhou Slink Medical Company Information
13.19.2 Suzhou Slink Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
13.19.3 Suzhou Slink Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Suzhou Slink Medical Main Business Overview
13.19.5 Suzhou Slink Medical Latest Developments
13.20 Shandong Lianfa
13.20.1 Shandong Lianfa Company Information
13.20.2 Shandong Lianfa Soft-Contact Blood Lancet Product Portfolios and Specifications
13.20.3 Shandong Lianfa Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Shandong Lianfa Main Business Overview
13.20.5 Shandong Lianfa Latest Developments
13.21 Puan Medical
13.21.1 Puan Medical Company Information
13.21.2 Puan Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
13.21.3 Puan Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Puan Medical Main Business Overview
13.21.5 Puan Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Soft-Contact Blood Lancet Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Soft-Contact Blood Lancet by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Soft-Contact Blood Lancet by Country/Region, 2021, 2025 & 2032
2.2 Soft-Contact Blood Lancet Segment by Type
2.2.1 Safety
2.2.2 Routine
2.2.3 Soft-Contact Blood Lancet Sales by Type
2.2.3.1 Global Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
2.2.3.2 Global Soft-Contact Blood Lancet Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Soft-Contact Blood Lancet Sale Price by Type (2021-2026)
2.3 Soft-Contact Blood Lancet Segment by Length
2.3.1 Standard Length
2.3.2 Short-length
2.3.3 Long-length
2.3.4 Soft-Contact Blood Lancet Sales by Length
2.3.4.1 Global Soft-Contact Blood Lancet Sales Market Share by Length (2021-2026)
2.3.4.2 Global Soft-Contact Blood Lancet Revenue and Market Share by Length (2021-2026)
2.3.4.3 Global Soft-Contact Blood Lancet Sale Price by Length (2021-2026)
2.4 Soft-Contact Blood Lancet Segment by Application
2.4.1 Newborn Screening
2.4.2 Blood Glucose Test
2.4.3 Rapid Complete Blood Count
2.4.4 Others
2.4.5 Soft-Contact Blood Lancet Sales by Application
2.4.5.1 Global Soft-Contact Blood Lancet Sale Market Share by Application (2021-2026)
2.4.5.2 Global Soft-Contact Blood Lancet Revenue and Market Share by Application (2021-2026)
2.4.5.3 Global Soft-Contact Blood Lancet Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Soft-Contact Blood Lancet Breakdown Data by Company
3.1.1 Global Soft-Contact Blood Lancet Annual Sales by Company (2021-2026)
3.1.2 Global Soft-Contact Blood Lancet Sales Market Share by Company (2021-2026)
3.2 Global Soft-Contact Blood Lancet Annual Revenue by Company (2021-2026)
3.2.1 Global Soft-Contact Blood Lancet Revenue by Company (2021-2026)
3.2.2 Global Soft-Contact Blood Lancet Revenue Market Share by Company (2021-2026)
3.3 Global Soft-Contact Blood Lancet Sale Price by Company
3.4 Key Manufacturers Soft-Contact Blood Lancet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Soft-Contact Blood Lancet Product Location Distribution
3.4.2 Players Soft-Contact Blood Lancet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SOFT-CONTACT BLOOD LANCET BY GEOGRAPHIC REGION
4.1 World Historic Soft-Contact Blood Lancet Market Size by Geographic Region (2021-2026)
4.1.1 Global Soft-Contact Blood Lancet Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Soft-Contact Blood Lancet Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Soft-Contact Blood Lancet Market Size by Country/Region (2021-2026)
4.2.1 Global Soft-Contact Blood Lancet Annual Sales by Country/Region (2021-2026)
4.2.2 Global Soft-Contact Blood Lancet Annual Revenue by Country/Region (2021-2026)
4.3 Americas Soft-Contact Blood Lancet Sales Growth
4.4 APAC Soft-Contact Blood Lancet Sales Growth
4.5 Europe Soft-Contact Blood Lancet Sales Growth
4.6 Middle East & Africa Soft-Contact Blood Lancet Sales Growth
5 AMERICAS
5.1 Americas Soft-Contact Blood Lancet Sales by Country
5.1.1 Americas Soft-Contact Blood Lancet Sales by Country (2021-2026)
5.1.2 Americas Soft-Contact Blood Lancet Revenue by Country (2021-2026)
5.2 Americas Soft-Contact Blood Lancet Sales by Type (2021-2026)
5.3 Americas Soft-Contact Blood Lancet Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Soft-Contact Blood Lancet Sales by Region
6.1.1 APAC Soft-Contact Blood Lancet Sales by Region (2021-2026)
6.1.2 APAC Soft-Contact Blood Lancet Revenue by Region (2021-2026)
6.2 APAC Soft-Contact Blood Lancet Sales by Type (2021-2026)
6.3 APAC Soft-Contact Blood Lancet Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Soft-Contact Blood Lancet by Country
7.1.1 Europe Soft-Contact Blood Lancet Sales by Country (2021-2026)
7.1.2 Europe Soft-Contact Blood Lancet Revenue by Country (2021-2026)
7.2 Europe Soft-Contact Blood Lancet Sales by Type (2021-2026)
7.3 Europe Soft-Contact Blood Lancet Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Soft-Contact Blood Lancet by Country
8.1.1 Middle East & Africa Soft-Contact Blood Lancet Sales by Country (2021-2026)
8.1.2 Middle East & Africa Soft-Contact Blood Lancet Revenue by Country (2021-2026)
8.2 Middle East & Africa Soft-Contact Blood Lancet Sales by Type (2021-2026)
8.3 Middle East & Africa Soft-Contact Blood Lancet Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Soft-Contact Blood Lancet
10.3 Manufacturing Process Analysis of Soft-Contact Blood Lancet
10.4 Industry Chain Structure of Soft-Contact Blood Lancet
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Soft-Contact Blood Lancet Distributors
11.3 Soft-Contact Blood Lancet Customer
12 WORLD FORECAST REVIEW FOR SOFT-CONTACT BLOOD LANCET BY GEOGRAPHIC REGION
12.1 Global Soft-Contact Blood Lancet Market Size Forecast by Region
12.1.1 Global Soft-Contact Blood Lancet Forecast by Region (2027-2032)
12.1.2 Global Soft-Contact Blood Lancet Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Soft-Contact Blood Lancet Forecast by Type (2027-2032)
12.7 Global Soft-Contact Blood Lancet Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Soft-Contact Blood Lancet Product Portfolios and Specifications
13.1.3 Roche Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Lifescan
13.2.1 Lifescan Company Information
13.2.2 Lifescan Soft-Contact Blood Lancet Product Portfolios and Specifications
13.2.3 Lifescan Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Lifescan Main Business Overview
13.2.5 Lifescan Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Soft-Contact Blood Lancet Product Portfolios and Specifications
13.3.3 BD Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 MTD Group
13.4.1 MTD Group Company Information
13.4.2 MTD Group Soft-Contact Blood Lancet Product Portfolios and Specifications
13.4.3 MTD Group Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MTD Group Main Business Overview
13.4.5 MTD Group Latest Developments
13.5 Greiner Bio One
13.5.1 Greiner Bio One Company Information
13.5.2 Greiner Bio One Soft-Contact Blood Lancet Product Portfolios and Specifications
13.5.3 Greiner Bio One Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Greiner Bio One Main Business Overview
13.5.5 Greiner Bio One Latest Developments
13.6 Owen Mumford
13.6.1 Owen Mumford Company Information
13.6.2 Owen Mumford Soft-Contact Blood Lancet Product Portfolios and Specifications
13.6.3 Owen Mumford Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Owen Mumford Main Business Overview
13.6.5 Owen Mumford Latest Developments
13.7 Cardinal Health
13.7.1 Cardinal Health Company Information
13.7.2 Cardinal Health Soft-Contact Blood Lancet Product Portfolios and Specifications
13.7.3 Cardinal Health Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cardinal Health Main Business Overview
13.7.5 Cardinal Health Latest Developments
13.8 Ascensia
13.8.1 Ascensia Company Information
13.8.2 Ascensia Soft-Contact Blood Lancet Product Portfolios and Specifications
13.8.3 Ascensia Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Ascensia Main Business Overview
13.8.5 Ascensia Latest Developments
13.9 Abbott
13.9.1 Abbott Company Information
13.9.2 Abbott Soft-Contact Blood Lancet Product Portfolios and Specifications
13.9.3 Abbott Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Abbott Main Business Overview
13.9.5 Abbott Latest Developments
13.10 B. Braun
13.10.1 B. Braun Company Information
13.10.2 B. Braun Soft-Contact Blood Lancet Product Portfolios and Specifications
13.10.3 B. Braun Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 B. Braun Main Business Overview
13.10.5 B. Braun Latest Developments
13.11 Terumo
13.11.1 Terumo Company Information
13.11.2 Terumo Soft-Contact Blood Lancet Product Portfolios and Specifications
13.11.3 Terumo Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Terumo Main Business Overview
13.11.5 Terumo Latest Developments
13.12 I-SENS
13.12.1 I-SENS Company Information
13.12.2 I-SENS Soft-Contact Blood Lancet Product Portfolios and Specifications
13.12.3 I-SENS Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 I-SENS Main Business Overview
13.12.5 I-SENS Latest Developments
13.13 Nipro
13.13.1 Nipro Company Information
13.13.2 Nipro Soft-Contact Blood Lancet Product Portfolios and Specifications
13.13.3 Nipro Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Nipro Main Business Overview
13.13.5 Nipro Latest Developments
13.14 ICU Medical
13.14.1 ICU Medical Company Information
13.14.2 ICU Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
13.14.3 ICU Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 ICU Medical Main Business Overview
13.14.5 ICU Medical Latest Developments
13.15 Sarstedt
13.15.1 Sarstedt Company Information
13.15.2 Sarstedt Soft-Contact Blood Lancet Product Portfolios and Specifications
13.15.3 Sarstedt Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sarstedt Main Business Overview
13.15.5 Sarstedt Latest Developments
13.16 Sannuo Biosensor
13.16.1 Sannuo Biosensor Company Information
13.16.2 Sannuo Biosensor Soft-Contact Blood Lancet Product Portfolios and Specifications
13.16.3 Sannuo Biosensor Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Sannuo Biosensor Main Business Overview
13.16.5 Sannuo Biosensor Latest Developments
13.17 Yuwell Medical
13.17.1 Yuwell Medical Company Information
13.17.2 Yuwell Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
13.17.3 Yuwell Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Yuwell Medical Main Business Overview
13.17.5 Yuwell Medical Latest Developments
13.18 Tianjin Huahong
13.18.1 Tianjin Huahong Company Information
13.18.2 Tianjin Huahong Soft-Contact Blood Lancet Product Portfolios and Specifications
13.18.3 Tianjin Huahong Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Tianjin Huahong Main Business Overview
13.18.5 Tianjin Huahong Latest Developments
13.19 Suzhou Slink Medical
13.19.1 Suzhou Slink Medical Company Information
13.19.2 Suzhou Slink Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
13.19.3 Suzhou Slink Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Suzhou Slink Medical Main Business Overview
13.19.5 Suzhou Slink Medical Latest Developments
13.20 Shandong Lianfa
13.20.1 Shandong Lianfa Company Information
13.20.2 Shandong Lianfa Soft-Contact Blood Lancet Product Portfolios and Specifications
13.20.3 Shandong Lianfa Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Shandong Lianfa Main Business Overview
13.20.5 Shandong Lianfa Latest Developments
13.21 Puan Medical
13.21.1 Puan Medical Company Information
13.21.2 Puan Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
13.21.3 Puan Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Puan Medical Main Business Overview
13.21.5 Puan Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Soft-Contact Blood Lancet Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Soft-Contact Blood Lancet Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Safety
Table 4. Major Players of Routine
Table 5. Global Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 6. Global Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Table 7. Global Soft-Contact Blood Lancet Revenue by Type (2021-2026) & ($ million)
Table 8. Global Soft-Contact Blood Lancet Revenue Market Share by Type (2021-2026)
Table 9. Global Soft-Contact Blood Lancet Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Standard Length
Table 11. Major Players of Short-length
Table 12. Major Players of Long-length
Table 13. Global Soft-Contact Blood Lancet Sales by Length (2021-2026) & (K Units)
Table 14. Global Soft-Contact Blood Lancet Sales Market Share by Length (2021-2026)
Table 15. Global Soft-Contact Blood Lancet Revenue by Length (2021-2026) & ($ million)
Table 16. Global Soft-Contact Blood Lancet Revenue Market Share by Length (2021-2026)
Table 17. Global Soft-Contact Blood Lancet Sale Price by Length (2021-2026) & (US$/Unit)
Table 18. Global Soft-Contact Blood Lancet Sale by Application (2021-2026) & (K Units)
Table 19. Global Soft-Contact Blood Lancet Sale Market Share by Application (2021-2026)
Table 20. Global Soft-Contact Blood Lancet Revenue by Application (2021-2026) & ($ million)
Table 21. Global Soft-Contact Blood Lancet Revenue Market Share by Application (2021-2026)
Table 22. Global Soft-Contact Blood Lancet Sale Price by Application (2021-2026) & (US$/Unit)
Table 23. Global Soft-Contact Blood Lancet Sales by Company (2021-2026) & (K Units)
Table 24. Global Soft-Contact Blood Lancet Sales Market Share by Company (2021-2026)
Table 25. Global Soft-Contact Blood Lancet Revenue by Company (2021-2026) & ($ millions)
Table 26. Global Soft-Contact Blood Lancet Revenue Market Share by Company (2021-2026)
Table 27. Global Soft-Contact Blood Lancet Sale Price by Company (2021-2026) & (US$/Unit)
Table 28. Key Manufacturers Soft-Contact Blood Lancet Producing Area Distribution and Sales Area
Table 29. Players Soft-Contact Blood Lancet Products Offered
Table 30. Soft-Contact Blood Lancet Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Market M&A Activity & Strategy
Table 33. Global Soft-Contact Blood Lancet Sales by Geographic Region (2021-2026) & (K Units)
Table 34. Global Soft-Contact Blood Lancet Sales Market Share Geographic Region (2021-2026)
Table 35. Global Soft-Contact Blood Lancet Revenue by Geographic Region (2021-2026) & ($ millions)
Table 36. Global Soft-Contact Blood Lancet Revenue Market Share by Geographic Region (2021-2026)
Table 37. Global Soft-Contact Blood Lancet Sales by Country/Region (2021-2026) & (K Units)
Table 38. Global Soft-Contact Blood Lancet Sales Market Share by Country/Region (2021-2026)
Table 39. Global Soft-Contact Blood Lancet Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Soft-Contact Blood Lancet Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Soft-Contact Blood Lancet Sales by Country (2021-2026) & (K Units)
Table 42. Americas Soft-Contact Blood Lancet Sales Market Share by Country (2021-2026)
Table 43. Americas Soft-Contact Blood Lancet Revenue by Country (2021-2026) & ($ millions)
Table 44. Americas Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 45. Americas Soft-Contact Blood Lancet Sales by Application (2021-2026) & (K Units)
Table 46. APAC Soft-Contact Blood Lancet Sales by Region (2021-2026) & (K Units)
Table 47. APAC Soft-Contact Blood Lancet Sales Market Share by Region (2021-2026)
Table 48. APAC Soft-Contact Blood Lancet Revenue by Region (2021-2026) & ($ millions)
Table 49. APAC Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 50. APAC Soft-Contact Blood Lancet Sales by Application (2021-2026) & (K Units)
Table 51. Europe Soft-Contact Blood Lancet Sales by Country (2021-2026) & (K Units)
Table 52. Europe Soft-Contact Blood Lancet Revenue by Country (2021-2026) & ($ millions)
Table 53. Europe Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 54. Europe Soft-Contact Blood Lancet Sales by Application (2021-2026) & (K Units)
Table 55. Middle East & Africa Soft-Contact Blood Lancet Sales by Country (2021-2026) & (K Units)
Table 56. Middle East & Africa Soft-Contact Blood Lancet Revenue Market Share by Country (2021-2026)
Table 57. Middle East & Africa Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 58. Middle East & Africa Soft-Contact Blood Lancet Sales by Application (2021-2026) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Soft-Contact Blood Lancet
Table 60. Key Market Challenges & Risks of Soft-Contact Blood Lancet
Table 61. Key Industry Trends of Soft-Contact Blood Lancet
Table 62. Soft-Contact Blood Lancet Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Soft-Contact Blood Lancet Distributors List
Table 65. Soft-Contact Blood Lancet Customer List
Table 66. Global Soft-Contact Blood Lancet Sales Forecast by Region (2027-2032) & (K Units)
Table 67. Global Soft-Contact Blood Lancet Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Americas Soft-Contact Blood Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Americas Soft-Contact Blood Lancet Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. APAC Soft-Contact Blood Lancet Sales Forecast by Region (2027-2032) & (K Units)
Table 71. APAC Soft-Contact Blood Lancet Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Europe Soft-Contact Blood Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 73. Europe Soft-Contact Blood Lancet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. Middle East & Africa Soft-Contact Blood Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Middle East & Africa Soft-Contact Blood Lancet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Global Soft-Contact Blood Lancet Sales Forecast by Type (2027-2032) & (K Units)
Table 77. Global Soft-Contact Blood Lancet Revenue Forecast by Type (2027-2032) & ($ millions)
Table 78. Global Soft-Contact Blood Lancet Sales Forecast by Application (2027-2032) & (K Units)
Table 79. Global Soft-Contact Blood Lancet Revenue Forecast by Application (2027-2032) & ($ millions)
Table 80. Roche Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 81. Roche Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 82. Roche Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Roche Main Business
Table 84. Roche Latest Developments
Table 85. Lifescan Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 86. Lifescan Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 87. Lifescan Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Lifescan Main Business
Table 89. Lifescan Latest Developments
Table 90. BD Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 91. BD Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 92. BD Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. BD Main Business
Table 94. BD Latest Developments
Table 95. MTD Group Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 96. MTD Group Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 97. MTD Group Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. MTD Group Main Business
Table 99. MTD Group Latest Developments
Table 100. Greiner Bio One Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 101. Greiner Bio One Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 102. Greiner Bio One Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Greiner Bio One Main Business
Table 104. Greiner Bio One Latest Developments
Table 105. Owen Mumford Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 106. Owen Mumford Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 107. Owen Mumford Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Owen Mumford Main Business
Table 109. Owen Mumford Latest Developments
Table 110. Cardinal Health Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 111. Cardinal Health Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 112. Cardinal Health Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Cardinal Health Main Business
Table 114. Cardinal Health Latest Developments
Table 115. Ascensia Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 116. Ascensia Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 117. Ascensia Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Ascensia Main Business
Table 119. Ascensia Latest Developments
Table 120. Abbott Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 121. Abbott Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 122. Abbott Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Abbott Main Business
Table 124. Abbott Latest Developments
Table 125. B. Braun Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 126. B. Braun Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 127. B. Braun Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. B. Braun Main Business
Table 129. B. Braun Latest Developments
Table 130. Terumo Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 131. Terumo Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 132. Terumo Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Terumo Main Business
Table 134. Terumo Latest Developments
Table 135. I-SENS Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 136. I-SENS Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 137. I-SENS Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. I-SENS Main Business
Table 139. I-SENS Latest Developments
Table 140. Nipro Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 141. Nipro Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 142. Nipro Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Nipro Main Business
Table 144. Nipro Latest Developments
Table 145. ICU Medical Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 146. ICU Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 147. ICU Medical Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. ICU Medical Main Business
Table 149. ICU Medical Latest Developments
Table 150. Sarstedt Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 151. Sarstedt Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 152. Sarstedt Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Sarstedt Main Business
Table 154. Sarstedt Latest Developments
Table 155. Sannuo Biosensor Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 156. Sannuo Biosensor Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 157. Sannuo Biosensor Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Sannuo Biosensor Main Business
Table 159. Sannuo Biosensor Latest Developments
Table 160. Yuwell Medical Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 161. Yuwell Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 162. Yuwell Medical Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Yuwell Medical Main Business
Table 164. Yuwell Medical Latest Developments
Table 165. Tianjin Huahong Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 166. Tianjin Huahong Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 167. Tianjin Huahong Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Tianjin Huahong Main Business
Table 169. Tianjin Huahong Latest Developments
Table 170. Suzhou Slink Medical Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 171. Suzhou Slink Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 172. Suzhou Slink Medical Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Suzhou Slink Medical Main Business
Table 174. Suzhou Slink Medical Latest Developments
Table 175. Shandong Lianfa Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 176. Shandong Lianfa Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 177. Shandong Lianfa Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Shandong Lianfa Main Business
Table 179. Shandong Lianfa Latest Developments
Table 180. Puan Medical Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 181. Puan Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 182. Puan Medical Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. Puan Medical Main Business
Table 184. Puan Medical Latest Developments
Table 1. Soft-Contact Blood Lancet Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Soft-Contact Blood Lancet Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Safety
Table 4. Major Players of Routine
Table 5. Global Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 6. Global Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Table 7. Global Soft-Contact Blood Lancet Revenue by Type (2021-2026) & ($ million)
Table 8. Global Soft-Contact Blood Lancet Revenue Market Share by Type (2021-2026)
Table 9. Global Soft-Contact Blood Lancet Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Standard Length
Table 11. Major Players of Short-length
Table 12. Major Players of Long-length
Table 13. Global Soft-Contact Blood Lancet Sales by Length (2021-2026) & (K Units)
Table 14. Global Soft-Contact Blood Lancet Sales Market Share by Length (2021-2026)
Table 15. Global Soft-Contact Blood Lancet Revenue by Length (2021-2026) & ($ million)
Table 16. Global Soft-Contact Blood Lancet Revenue Market Share by Length (2021-2026)
Table 17. Global Soft-Contact Blood Lancet Sale Price by Length (2021-2026) & (US$/Unit)
Table 18. Global Soft-Contact Blood Lancet Sale by Application (2021-2026) & (K Units)
Table 19. Global Soft-Contact Blood Lancet Sale Market Share by Application (2021-2026)
Table 20. Global Soft-Contact Blood Lancet Revenue by Application (2021-2026) & ($ million)
Table 21. Global Soft-Contact Blood Lancet Revenue Market Share by Application (2021-2026)
Table 22. Global Soft-Contact Blood Lancet Sale Price by Application (2021-2026) & (US$/Unit)
Table 23. Global Soft-Contact Blood Lancet Sales by Company (2021-2026) & (K Units)
Table 24. Global Soft-Contact Blood Lancet Sales Market Share by Company (2021-2026)
Table 25. Global Soft-Contact Blood Lancet Revenue by Company (2021-2026) & ($ millions)
Table 26. Global Soft-Contact Blood Lancet Revenue Market Share by Company (2021-2026)
Table 27. Global Soft-Contact Blood Lancet Sale Price by Company (2021-2026) & (US$/Unit)
Table 28. Key Manufacturers Soft-Contact Blood Lancet Producing Area Distribution and Sales Area
Table 29. Players Soft-Contact Blood Lancet Products Offered
Table 30. Soft-Contact Blood Lancet Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Market M&A Activity & Strategy
Table 33. Global Soft-Contact Blood Lancet Sales by Geographic Region (2021-2026) & (K Units)
Table 34. Global Soft-Contact Blood Lancet Sales Market Share Geographic Region (2021-2026)
Table 35. Global Soft-Contact Blood Lancet Revenue by Geographic Region (2021-2026) & ($ millions)
Table 36. Global Soft-Contact Blood Lancet Revenue Market Share by Geographic Region (2021-2026)
Table 37. Global Soft-Contact Blood Lancet Sales by Country/Region (2021-2026) & (K Units)
Table 38. Global Soft-Contact Blood Lancet Sales Market Share by Country/Region (2021-2026)
Table 39. Global Soft-Contact Blood Lancet Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Soft-Contact Blood Lancet Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Soft-Contact Blood Lancet Sales by Country (2021-2026) & (K Units)
Table 42. Americas Soft-Contact Blood Lancet Sales Market Share by Country (2021-2026)
Table 43. Americas Soft-Contact Blood Lancet Revenue by Country (2021-2026) & ($ millions)
Table 44. Americas Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 45. Americas Soft-Contact Blood Lancet Sales by Application (2021-2026) & (K Units)
Table 46. APAC Soft-Contact Blood Lancet Sales by Region (2021-2026) & (K Units)
Table 47. APAC Soft-Contact Blood Lancet Sales Market Share by Region (2021-2026)
Table 48. APAC Soft-Contact Blood Lancet Revenue by Region (2021-2026) & ($ millions)
Table 49. APAC Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 50. APAC Soft-Contact Blood Lancet Sales by Application (2021-2026) & (K Units)
Table 51. Europe Soft-Contact Blood Lancet Sales by Country (2021-2026) & (K Units)
Table 52. Europe Soft-Contact Blood Lancet Revenue by Country (2021-2026) & ($ millions)
Table 53. Europe Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 54. Europe Soft-Contact Blood Lancet Sales by Application (2021-2026) & (K Units)
Table 55. Middle East & Africa Soft-Contact Blood Lancet Sales by Country (2021-2026) & (K Units)
Table 56. Middle East & Africa Soft-Contact Blood Lancet Revenue Market Share by Country (2021-2026)
Table 57. Middle East & Africa Soft-Contact Blood Lancet Sales by Type (2021-2026) & (K Units)
Table 58. Middle East & Africa Soft-Contact Blood Lancet Sales by Application (2021-2026) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Soft-Contact Blood Lancet
Table 60. Key Market Challenges & Risks of Soft-Contact Blood Lancet
Table 61. Key Industry Trends of Soft-Contact Blood Lancet
Table 62. Soft-Contact Blood Lancet Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Soft-Contact Blood Lancet Distributors List
Table 65. Soft-Contact Blood Lancet Customer List
Table 66. Global Soft-Contact Blood Lancet Sales Forecast by Region (2027-2032) & (K Units)
Table 67. Global Soft-Contact Blood Lancet Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Americas Soft-Contact Blood Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Americas Soft-Contact Blood Lancet Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. APAC Soft-Contact Blood Lancet Sales Forecast by Region (2027-2032) & (K Units)
Table 71. APAC Soft-Contact Blood Lancet Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Europe Soft-Contact Blood Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 73. Europe Soft-Contact Blood Lancet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. Middle East & Africa Soft-Contact Blood Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Middle East & Africa Soft-Contact Blood Lancet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Global Soft-Contact Blood Lancet Sales Forecast by Type (2027-2032) & (K Units)
Table 77. Global Soft-Contact Blood Lancet Revenue Forecast by Type (2027-2032) & ($ millions)
Table 78. Global Soft-Contact Blood Lancet Sales Forecast by Application (2027-2032) & (K Units)
Table 79. Global Soft-Contact Blood Lancet Revenue Forecast by Application (2027-2032) & ($ millions)
Table 80. Roche Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 81. Roche Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 82. Roche Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Roche Main Business
Table 84. Roche Latest Developments
Table 85. Lifescan Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 86. Lifescan Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 87. Lifescan Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Lifescan Main Business
Table 89. Lifescan Latest Developments
Table 90. BD Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 91. BD Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 92. BD Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. BD Main Business
Table 94. BD Latest Developments
Table 95. MTD Group Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 96. MTD Group Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 97. MTD Group Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. MTD Group Main Business
Table 99. MTD Group Latest Developments
Table 100. Greiner Bio One Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 101. Greiner Bio One Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 102. Greiner Bio One Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Greiner Bio One Main Business
Table 104. Greiner Bio One Latest Developments
Table 105. Owen Mumford Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 106. Owen Mumford Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 107. Owen Mumford Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Owen Mumford Main Business
Table 109. Owen Mumford Latest Developments
Table 110. Cardinal Health Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 111. Cardinal Health Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 112. Cardinal Health Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Cardinal Health Main Business
Table 114. Cardinal Health Latest Developments
Table 115. Ascensia Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 116. Ascensia Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 117. Ascensia Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Ascensia Main Business
Table 119. Ascensia Latest Developments
Table 120. Abbott Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 121. Abbott Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 122. Abbott Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Abbott Main Business
Table 124. Abbott Latest Developments
Table 125. B. Braun Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 126. B. Braun Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 127. B. Braun Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. B. Braun Main Business
Table 129. B. Braun Latest Developments
Table 130. Terumo Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 131. Terumo Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 132. Terumo Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Terumo Main Business
Table 134. Terumo Latest Developments
Table 135. I-SENS Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 136. I-SENS Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 137. I-SENS Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. I-SENS Main Business
Table 139. I-SENS Latest Developments
Table 140. Nipro Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 141. Nipro Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 142. Nipro Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Nipro Main Business
Table 144. Nipro Latest Developments
Table 145. ICU Medical Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 146. ICU Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 147. ICU Medical Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. ICU Medical Main Business
Table 149. ICU Medical Latest Developments
Table 150. Sarstedt Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 151. Sarstedt Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 152. Sarstedt Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Sarstedt Main Business
Table 154. Sarstedt Latest Developments
Table 155. Sannuo Biosensor Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 156. Sannuo Biosensor Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 157. Sannuo Biosensor Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Sannuo Biosensor Main Business
Table 159. Sannuo Biosensor Latest Developments
Table 160. Yuwell Medical Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 161. Yuwell Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 162. Yuwell Medical Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Yuwell Medical Main Business
Table 164. Yuwell Medical Latest Developments
Table 165. Tianjin Huahong Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 166. Tianjin Huahong Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 167. Tianjin Huahong Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Tianjin Huahong Main Business
Table 169. Tianjin Huahong Latest Developments
Table 170. Suzhou Slink Medical Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 171. Suzhou Slink Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 172. Suzhou Slink Medical Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Suzhou Slink Medical Main Business
Table 174. Suzhou Slink Medical Latest Developments
Table 175. Shandong Lianfa Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 176. Shandong Lianfa Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 177. Shandong Lianfa Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Shandong Lianfa Main Business
Table 179. Shandong Lianfa Latest Developments
Table 180. Puan Medical Basic Information, Soft-Contact Blood Lancet Manufacturing Base, Sales Area and Its Competitors
Table 181. Puan Medical Soft-Contact Blood Lancet Product Portfolios and Specifications
Table 182. Puan Medical Soft-Contact Blood Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. Puan Medical Main Business
Table 184. Puan Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Soft-Contact Blood Lancet
Figure 2. Soft-Contact Blood Lancet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Soft-Contact Blood Lancet Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Soft-Contact Blood Lancet Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Soft-Contact Blood Lancet Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Soft-Contact Blood Lancet Sales Market Share by Country/Region (2025)
Figure 10. Soft-Contact Blood Lancet Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Safety
Figure 12. Product Picture of Routine
Figure 13. Global Soft-Contact Blood Lancet Sales Market Share by Type in 2026
Figure 14. Global Soft-Contact Blood Lancet Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Standard Length
Figure 16. Product Picture of Short-length
Figure 17. Product Picture of Long-length
Figure 18. Global Soft-Contact Blood Lancet Sales Market Share by Length in 2026
Figure 19. Global Soft-Contact Blood Lancet Revenue Market Share by Length (2021-2026)
Figure 20. Soft-Contact Blood Lancet Consumed in Newborn Screening
Figure 21. Global Soft-Contact Blood Lancet Market: Newborn Screening (2021-2026) & (K Units)
Figure 22. Soft-Contact Blood Lancet Consumed in Blood Glucose Test
Figure 23. Global Soft-Contact Blood Lancet Market: Blood Glucose Test (2021-2026) & (K Units)
Figure 24. Soft-Contact Blood Lancet Consumed in Rapid Complete Blood Count
Figure 25. Global Soft-Contact Blood Lancet Market: Rapid Complete Blood Count (2021-2026) & (K Units)
Figure 26. Soft-Contact Blood Lancet Consumed in Others
Figure 27. Global Soft-Contact Blood Lancet Market: Others (2021-2026) & (K Units)
Figure 28. Global Soft-Contact Blood Lancet Sale Market Share by Application (2025)
Figure 29. Global Soft-Contact Blood Lancet Revenue Market Share by Application in 2026
Figure 30. Soft-Contact Blood Lancet Sales by Company in 2026 (K Units)
Figure 31. Global Soft-Contact Blood Lancet Sales Market Share by Company in 2026
Figure 32. Soft-Contact Blood Lancet Revenue by Company in 2026 ($ millions)
Figure 33. Global Soft-Contact Blood Lancet Revenue Market Share by Company in 2026
Figure 34. Global Soft-Contact Blood Lancet Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Soft-Contact Blood Lancet Revenue Market Share by Geographic Region in 2026
Figure 36. Americas Soft-Contact Blood Lancet Sales 2021-2026 (K Units)
Figure 37. Americas Soft-Contact Blood Lancet Revenue 2021-2026 ($ millions)
Figure 38. APAC Soft-Contact Blood Lancet Sales 2021-2026 (K Units)
Figure 39. APAC Soft-Contact Blood Lancet Revenue 2021-2026 ($ millions)
Figure 40. Europe Soft-Contact Blood Lancet Sales 2021-2026 (K Units)
Figure 41. Europe Soft-Contact Blood Lancet Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Soft-Contact Blood Lancet Sales 2021-2026 (K Units)
Figure 43. Middle East & Africa Soft-Contact Blood Lancet Revenue 2021-2026 ($ millions)
Figure 44. Americas Soft-Contact Blood Lancet Sales Market Share by Country in 2026
Figure 45. Americas Soft-Contact Blood Lancet Revenue Market Share by Country (2021-2026)
Figure 46. Americas Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Figure 47. Americas Soft-Contact Blood Lancet Sales Market Share by Application (2021-2026)
Figure 48. United States Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Soft-Contact Blood Lancet Sales Market Share by Region in 2026
Figure 53. APAC Soft-Contact Blood Lancet Revenue Market Share by Region (2021-2026)
Figure 54. APAC Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Figure 55. APAC Soft-Contact Blood Lancet Sales Market Share by Application (2021-2026)
Figure 56. China Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 60. India Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Soft-Contact Blood Lancet Sales Market Share by Country in 2026
Figure 64. Europe Soft-Contact Blood Lancet Revenue Market Share by Country (2021-2026)
Figure 65. Europe Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Figure 66. Europe Soft-Contact Blood Lancet Sales Market Share by Application (2021-2026)
Figure 67. Germany Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 68. France Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Soft-Contact Blood Lancet Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Soft-Contact Blood Lancet Sales Market Share by Application (2021-2026)
Figure 75. Egypt Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Soft-Contact Blood Lancet in 2026
Figure 81. Manufacturing Process Analysis of Soft-Contact Blood Lancet
Figure 82. Industry Chain Structure of Soft-Contact Blood Lancet
Figure 83. Channels of Distribution
Figure 84. Global Soft-Contact Blood Lancet Sales Market Forecast by Region (2027-2032)
Figure 85. Global Soft-Contact Blood Lancet Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Soft-Contact Blood Lancet Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Soft-Contact Blood Lancet Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Soft-Contact Blood Lancet Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Soft-Contact Blood Lancet Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Soft-Contact Blood Lancet
Figure 2. Soft-Contact Blood Lancet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Soft-Contact Blood Lancet Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Soft-Contact Blood Lancet Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Soft-Contact Blood Lancet Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Soft-Contact Blood Lancet Sales Market Share by Country/Region (2025)
Figure 10. Soft-Contact Blood Lancet Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Safety
Figure 12. Product Picture of Routine
Figure 13. Global Soft-Contact Blood Lancet Sales Market Share by Type in 2026
Figure 14. Global Soft-Contact Blood Lancet Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Standard Length
Figure 16. Product Picture of Short-length
Figure 17. Product Picture of Long-length
Figure 18. Global Soft-Contact Blood Lancet Sales Market Share by Length in 2026
Figure 19. Global Soft-Contact Blood Lancet Revenue Market Share by Length (2021-2026)
Figure 20. Soft-Contact Blood Lancet Consumed in Newborn Screening
Figure 21. Global Soft-Contact Blood Lancet Market: Newborn Screening (2021-2026) & (K Units)
Figure 22. Soft-Contact Blood Lancet Consumed in Blood Glucose Test
Figure 23. Global Soft-Contact Blood Lancet Market: Blood Glucose Test (2021-2026) & (K Units)
Figure 24. Soft-Contact Blood Lancet Consumed in Rapid Complete Blood Count
Figure 25. Global Soft-Contact Blood Lancet Market: Rapid Complete Blood Count (2021-2026) & (K Units)
Figure 26. Soft-Contact Blood Lancet Consumed in Others
Figure 27. Global Soft-Contact Blood Lancet Market: Others (2021-2026) & (K Units)
Figure 28. Global Soft-Contact Blood Lancet Sale Market Share by Application (2025)
Figure 29. Global Soft-Contact Blood Lancet Revenue Market Share by Application in 2026
Figure 30. Soft-Contact Blood Lancet Sales by Company in 2026 (K Units)
Figure 31. Global Soft-Contact Blood Lancet Sales Market Share by Company in 2026
Figure 32. Soft-Contact Blood Lancet Revenue by Company in 2026 ($ millions)
Figure 33. Global Soft-Contact Blood Lancet Revenue Market Share by Company in 2026
Figure 34. Global Soft-Contact Blood Lancet Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Soft-Contact Blood Lancet Revenue Market Share by Geographic Region in 2026
Figure 36. Americas Soft-Contact Blood Lancet Sales 2021-2026 (K Units)
Figure 37. Americas Soft-Contact Blood Lancet Revenue 2021-2026 ($ millions)
Figure 38. APAC Soft-Contact Blood Lancet Sales 2021-2026 (K Units)
Figure 39. APAC Soft-Contact Blood Lancet Revenue 2021-2026 ($ millions)
Figure 40. Europe Soft-Contact Blood Lancet Sales 2021-2026 (K Units)
Figure 41. Europe Soft-Contact Blood Lancet Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Soft-Contact Blood Lancet Sales 2021-2026 (K Units)
Figure 43. Middle East & Africa Soft-Contact Blood Lancet Revenue 2021-2026 ($ millions)
Figure 44. Americas Soft-Contact Blood Lancet Sales Market Share by Country in 2026
Figure 45. Americas Soft-Contact Blood Lancet Revenue Market Share by Country (2021-2026)
Figure 46. Americas Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Figure 47. Americas Soft-Contact Blood Lancet Sales Market Share by Application (2021-2026)
Figure 48. United States Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Soft-Contact Blood Lancet Sales Market Share by Region in 2026
Figure 53. APAC Soft-Contact Blood Lancet Revenue Market Share by Region (2021-2026)
Figure 54. APAC Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Figure 55. APAC Soft-Contact Blood Lancet Sales Market Share by Application (2021-2026)
Figure 56. China Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 60. India Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Soft-Contact Blood Lancet Sales Market Share by Country in 2026
Figure 64. Europe Soft-Contact Blood Lancet Revenue Market Share by Country (2021-2026)
Figure 65. Europe Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Figure 66. Europe Soft-Contact Blood Lancet Sales Market Share by Application (2021-2026)
Figure 67. Germany Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 68. France Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Soft-Contact Blood Lancet Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Soft-Contact Blood Lancet Sales Market Share by Application (2021-2026)
Figure 75. Egypt Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Soft-Contact Blood Lancet Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Soft-Contact Blood Lancet in 2026
Figure 81. Manufacturing Process Analysis of Soft-Contact Blood Lancet
Figure 82. Industry Chain Structure of Soft-Contact Blood Lancet
Figure 83. Channels of Distribution
Figure 84. Global Soft-Contact Blood Lancet Sales Market Forecast by Region (2027-2032)
Figure 85. Global Soft-Contact Blood Lancet Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Soft-Contact Blood Lancet Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Soft-Contact Blood Lancet Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Soft-Contact Blood Lancet Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Soft-Contact Blood Lancet Revenue Market Share Forecast by Application (2027-2032)
